Postgraduate Course in Pharmaceutical Medicine A warm welcome to all participants.

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Drug Discovery: an Industrial Process How are drugs discovered and developed? Dr Steve Carney, Managing Editor, Drug Discovery Today.
Parkinson’s disease (PD) is one of the most common chronic progressive neurodegenerative diseases. PD has a prevalence of 1.2 million people in Europe.
Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.
1 Xavier University of Louisiana College of Pharmacy Curriculum Map – NAPLEX Competencies Map by Course.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
What Challenges? How do we prepare students for a career in Pharmacology? How do we combine elements of “traditional pharmacology with modern concepts.
What Do Toxicologists Do?
1 Course. 3 U nique options. Biomedical Science Discoveries, Diagnostics and Cures 1.
ELEMENTS OF THE TRAINING CYCLE
Drug Discovery Exchange Fellowship Workshop 9 th -10 th December Mike Hardman IMI EMTRAIN Coordinator.
Pharmacology embraces knowledge of the sources, chemical properties, biological effects and therapeutic uses of drugs. In general terms, pharmacology.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke U.S. DEPARTMENT OF HEALTH.
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Stefan Franzén Introduction to clinical trials.
College of Pharmaceutical Sciences Irma Meijerman
The Human Genome Project: prospects for cardiology Claude L’Enfant MD Director, National Heart, Lung, and Blood Institute National Institutes of Health,
TOPICS IN (NANO) BIOTECHNOLOGY
Clinical Pharmacy Part 2
This curriculum is available on the NWABR website, Permission granted for educational use ©2012 Northwest Association for Biomedical.
Integrated Biomedical Information for Better Health Workprogramme Call 4 IST Conference- Networking Session.
NT CVD : Development and Validation of new Diagnostic, Preventive and Therapeutic Tools for the Prevention of Cardiovascular Disease in Chronic Kidney.
PHC 222 Medicinal Chemistry-1- Part(I) Dr. Huda Al Salem Lecture (1)
Drug Discovery Process Massimiliano Beltramo, PhD.
Pharmacology UG-Course Touqeer Ahmed PhD 19 th February, 2015 Atta-ur-Rahman School of Applied Biosciences National University of Sciences and Technology.
Dr Dave Lewis School of Biomedical Sciences FACULTY OF BIOLOGICAL SCIENCES Integrating neuro-ethics into Secondary and Tertiary education:
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 2: Section 9.4 (Lead compounds from the natural world)
Shelter Training 08b – Belgium, 16 th –18 th November, 2008 based on content developed by This session will look at how to prepare Shelter Training for.
RMIT University© 1 Health Innovations Research Institute (HIRi) Translating fundamental science into.
Overview of Bioinformatics 1 Module Denis Manley..
Privacy Symposium / HIPAA Summit
The pharmaceutical R&D process
Department of Chemistry Seminar Announcement Date/Time/VenueTitle/Speaker 12 Jan (Wed) 11am – S8 Level 3 Executive Classroom PET in Neuroscience.
○ Area Yonsei Biomedical Science and Technology Initiative (YBSTI)
? ? ? ? ? ? What valuable skills can you develop by studying chemistry? ? ? ? ? ? ? ? ? ? ? ? ?
Joe Pekny, Professor Chemical Engineering Director, e-Enterprise Center Discovery Park Marietta Harrison, Professor Medicinal Chemistry & Molecular Pharmacology.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
INTRODUCTION TO THE SKILL MODULE. Al-Ma’arifa Science &Technology Colleges (MSTC) College of Medicine.
Responses to the student’s evaluation Pharmaceutical Chemistry Department.
I farmaci innovativi in una prospettiva europea Giuseppe M.C. Rosano, MD, PhD Cardiovascular and Cell Sciences Research Institute, St George's University.
Course: Pharmacognosy-I Course Instructor: Nishat Jahan.
Molecular Modeling in Drug Discovery: an Overview
Medicinal Chemistry Lecture – I Introduction and Course Overview Joseph O. Oweta B. Pharm (MUST)
Advantages of Good Drug-like Properties 손한표.
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
Horizon societal challenge 1 ICT for Health, demographic change and well-being – Work Programme Horizon 2020 Health, Demographic Change.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 9 DRUG DISCOVERY: FINDING A LEAD Part 1: Sections
Rheumatology Mastery in Ankylosing Spondylitis
Horizon 2020 Health, Demographic Change and Well-being Open Info Day 12 May 2016, Bruxelles NCP training Amalia-Irina Vlad ICT for Health, demographic.
Training and Development
Medicinal Chemistry III
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))
The DMDG In-Vitro Technology Training Course
Intersecting different databases to define the inner and outer limits of the data-supported druggable proteome
E-Learning & Virtual Classroom
ATOM Accelerating Therapeutics for Opportunities in Medicine
Action: BM0806 Recent Advances in Histamine Receptor H4R Research
An Introduction to Medicinal Chemistry 3/e
Speaker Names, Credentials, Full Title
Branko Stefanovic Biomedical Sciences
The increasing availability of quantitative biological data from the human genome project, coupled with advances in instrumentation, reagents, methodologies,
Drug Design and Drug Discovery
Nat. Rev. Urol. doi: /nrurol
Rational for the 5R Philosophy
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Biopharmaceutics Pharmacy Technician.
Volume 21, Issue 9, Pages (September 2014)
Pillars of WARF Therapeutics: Invest - Develop - Partner
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
Presentation transcript:

Postgraduate Course in Pharmaceutical Medicine A warm welcome to all participants

INTRODUCTION Postgraduate Course in Pharmaceutical Medicine

Background Management Structure BrAPP Membership Modules Module Updates & Reviews Module Feedback Year Representative Handouts Speakers & Workshop leaders CV Speakers Briefing Workshops & Interactive Sessions Reading List Course Reference Books Postgraduate Course in Pharmaceutical Medicine

Networking Hotel Venues Module Booking Signing the Register House Rules –Mobile phones –Messages –Accommodation payments Day delegates –Correspondence Address –Change of address –Communication

Postgraduate Course in Pharmaceutical Medicine Faculty of Pharmaceutical Medicine –Dip Pharm Med –HMT - Basic and Advanced –CPD/CE Quality Assurance –Module Review –Course Critique –Year Reps Feedback Module Reading Pack Module MCQ Quiz Course Accreditation

Postgraduate Course in Pharmaceutical Medicine Principles of Discovery of New Medicines and Development Planning – Syllabus Disease models; target identification, validation and selection Receptor-based approaches: agonists, antagonists, enzyme inhibitors, genomics, proteomics The principle steps in discovering, modifying, assessing and patenting new chemical and biological compounds Other therapeutic approaches e.g. herbal and other natural products, drug- coupled devices and advanced therapies Lead optimisation and candidate compound selection for further development In vitro and in vivo testing of new compounds Relationship between animal and human pharmacology, molecular biology and physiology e.g. biomarkers, functional imaging, modelling and simulation Principles of translational medicine

Postgraduate Course in Pharmaceutical Medicine Principles of Discovery of New Medicines and Development Planning – Syllabus (cont) Principle steps in discovering, modifying, assessing and patenting new chemical and biological compounds (including advanced therapies) according to their therapeutic indication Resource planning (in terms of project management, budgeting and cost-control) involved in the management of a drug related programme Role of pathophysiology and molecular biology-based pharmacology in drug development Principles of translational research and its role in drug development Functions and elements (including business aspects) involved in the integrated development of a new drug